JPH03280836A - Feed additive for ruminant - Google Patents
Feed additive for ruminantInfo
- Publication number
- JPH03280836A JPH03280836A JP2080804A JP8080490A JPH03280836A JP H03280836 A JPH03280836 A JP H03280836A JP 2080804 A JP2080804 A JP 2080804A JP 8080490 A JP8080490 A JP 8080490A JP H03280836 A JPH03280836 A JP H03280836A
- Authority
- JP
- Japan
- Prior art keywords
- biologically active
- substance
- ruminants
- protective
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000282849 Ruminantia Species 0.000 title claims description 34
- 239000003674 animal food additive Substances 0.000 title claims description 19
- 230000001681 protective effect Effects 0.000 claims abstract description 25
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 24
- 229930195729 fatty acid Natural products 0.000 claims abstract description 24
- 239000000194 fatty acid Substances 0.000 claims abstract description 24
- 239000008187 granular material Substances 0.000 claims abstract description 22
- 239000000126 substance Substances 0.000 claims abstract description 19
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 14
- -1 fatty acid salt Chemical class 0.000 claims abstract description 13
- 229940088623 biologically active substance Drugs 0.000 claims abstract description 11
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 10
- 230000002378 acidificating effect Effects 0.000 claims abstract description 8
- 230000007935 neutral effect Effects 0.000 claims abstract description 8
- 238000002844 melting Methods 0.000 claims abstract description 6
- 230000008018 melting Effects 0.000 claims abstract description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 5
- 229930182817 methionine Natural products 0.000 claims abstract description 5
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 claims abstract description 3
- 229960005337 lysine hydrochloride Drugs 0.000 claims abstract description 3
- 229940088594 vitamin Drugs 0.000 claims abstract description 3
- 229930003231 vitamin Natural products 0.000 claims abstract description 3
- 235000013343 vitamin Nutrition 0.000 claims abstract description 3
- 239000011782 vitamin Substances 0.000 claims abstract description 3
- 239000000654 additive Substances 0.000 claims abstract 3
- 230000000996 additive effect Effects 0.000 claims abstract 3
- 229960004452 methionine Drugs 0.000 claims abstract 2
- 239000013543 active substance Substances 0.000 claims description 29
- 239000011253 protective coating Substances 0.000 claims description 4
- 210000004767 rumen Anatomy 0.000 abstract description 13
- 210000003165 abomasum Anatomy 0.000 abstract description 12
- 210000004798 organs belonging to the digestive system Anatomy 0.000 abstract description 11
- 239000011248 coating agent Substances 0.000 abstract description 8
- 238000000576 coating method Methods 0.000 abstract description 8
- 210000004051 gastric juice Anatomy 0.000 abstract description 4
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000012530 fluid Substances 0.000 description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 239000000273 veterinary drug Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- WUNWNURVJGOTHZ-YFKPBYRVSA-N (2s)-2-(hydroxymethylamino)-4-methylsulfanylbutanoic acid Chemical compound CSCC[C@@H](C(O)=O)NCO WUNWNURVJGOTHZ-YFKPBYRVSA-N 0.000 description 1
- RYUVEEZMMFRGGS-NRFANRHFSA-N (2s)-4-methylsulfanyl-2-(octadecanoylamino)butanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCSC RYUVEEZMMFRGGS-NRFANRHFSA-N 0.000 description 1
- NOMBOSYULRDSOO-YRBAHSOBSA-N (2s)-4-methylsulfanyl-2-[[(z)-octadec-9-enyl]amino]butanoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCN[C@H](C(O)=O)CCSC NOMBOSYULRDSOO-YRBAHSOBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- IWLYFBGNNDXONS-UHFFFAOYSA-N 2-hydroxy-2-sulfanylpentanoic acid Chemical compound CCCC(O)(S)C(O)=O IWLYFBGNNDXONS-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007922 dissolution test Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- IZXGZAJMDLJLMF-UHFFFAOYSA-N methylaminomethanol Chemical compound CNCO IZXGZAJMDLJLMF-UHFFFAOYSA-N 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 230000022676 rumination Effects 0.000 description 1
- 208000015212 rumination disease Diseases 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、反芻動物用飼料添加剤に係り、さらに詳しく
は、反芻動物の第1胃の胃液から生物学的活性物質を保
護し、第4胃以降の消化器官において効率良く吸収させ
るべく、生物学的活性物質を含有する核顆粒を脂肪酸塩
の保護皮膜で被覆した製剤に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a feed additive for ruminants, and more particularly, it protects biologically active substances from the gastric juice of the rumen of ruminants. The present invention relates to a preparation in which core granules containing a biologically active substance are coated with a protective coating of a fatty acid salt in order to be efficiently absorbed in the digestive organs starting from the four stomachs.
本発明の反芻動物用飼料添加剤は、濃厚飼料に添加混合
し、牛、羊等の反芻動物に経口投与することができ、ア
ミノ酸、タンパク質、動物医薬等の生物学的活性物質を
効率よく吸収させるための製剤として好適に使用される
。The feed additive for ruminants of the present invention can be added to concentrated feed and orally administered to ruminants such as cattle and sheep, and can efficiently absorb biologically active substances such as amino acids, proteins, and veterinary drugs. It is suitably used as a formulation for
アミノ酸、タンパク質、動物医薬等の生物学的活性物質
を反芻動物に経口投与した場合、反芻動物の第1胃の胃
液に存在する微生物により分解されるため、生物学的活
性物質が有効に吸収されない。When biologically active substances such as amino acids, proteins, and veterinary drugs are orally administered to ruminants, they are degraded by microorganisms present in the gastric juice of the rumen of the ruminant, so the biologically active substances are not effectively absorbed. .
したがって、これらの生物学的活性物質を効率よく吸収
させることを目的として、生物学的活性物質を油脂等の
第1胃胃液に対して安定な物質で被覆保護し、第4胃以
降の消化器官で生物学的活性物質を放出させる反芻動物
用飼料添加剤が種々提案されており(特開昭56−15
4956号公報、特開昭61−151133号公報等参
照)、本発明の出願人も生物学的活性物質を、硬化油等
の保護物質にその保護物質の第4胃以降の消化器官にお
ける崩壊を賦与する目的でキトサンを加えて保護した製
剤を提案しく特開昭58−175449号公報、特開昭
59−198946号公報等参照)、ラフチット■の名
称で上布している。Therefore, in order to efficiently absorb these biologically active substances, the biologically active substances are coated and protected with a substance that is stable against the ruminal fluid, such as oil, and the digestive organs from the abomasum onward are protected. Various feed additives for ruminants that release biologically active substances have been proposed (Japanese Unexamined Patent Publication No. 56-15).
4956, Japanese Unexamined Patent Publication No. 61-151133, etc.), the applicant of the present invention also added a biologically active substance to a protective substance such as hydrogenated oil so that the protective substance disintegrates in the abomasum and subsequent digestive organs. A preparation protected by adding chitosan for the purpose of imparting has been proposed and published under the name Lafchit (see JP-A-58-175449, JP-A-59-198946, etc.).
一方、反芻動物の第1胃をバイパスし、第4胃以降の消
化器官で高効率で吸収するエネルギー源として、炭素数
14.16および/または18の脂肪酸のカルシウム、
マグネシウム等の2価金属塩が提案され(LISP 4
,826,694明細書参照)、天然油脂から製造され
た混合脂肪酸のカルシウム塩(以下「バイパス油脂」と
称す)が市販されている。On the other hand, as an energy source that bypasses the rumen of ruminants and is absorbed with high efficiency in the digestive organs after the abomasum, calcium of fatty acids having 14.16 and/or 18 carbon atoms,
Divalent metal salts such as magnesium have been proposed (LISP 4
, 826, 694), and calcium salts of mixed fatty acids produced from natural fats and oils (hereinafter referred to as "bypass fats and oils") are commercially available.
またこれらのバイパス油脂をその融点以上の温度に加熱
して軟化し、その中に生物学的活性物質を添加混合した
後、冷却固化して反芻動物用飼料添加剤の製造法が知ら
れている(特開昭63−313546号公報参照)。There is also a known method for producing feed additives for ruminants by heating these bypass fats and oils to a temperature above their melting point to soften them, adding and mixing biologically active substances therein, and then cooling and solidifying the mixture. (Refer to Japanese Patent Application Laid-Open No. 63-313546).
前記引用した硬化油等の保護物質で生物学的活性物質を
被覆保護した反芻動物用飼料添加剤においては、生物学
的活性物質の第1胃バイパス性および第4胃以降の消化
器官での放出性に極めて優れているが、貯蔵安定性、特
に40°C以上の高温における熱安定性に問題があった
。In feed additives for ruminants in which biologically active substances are coated and protected with the above-mentioned protective substances such as hydrogenated oil, the biologically active substances have ruminal bypass properties and are released in the digestive tract from the abomasum onward. However, there were problems with storage stability, especially thermal stability at high temperatures of 40°C or higher.
一方、バイパス油脂は、硬化油等に比較して融点が高く
、熱安定性に優れているため、生物学的活性物質をバイ
パス油脂で被覆保護した製剤は、熱安定性に優れること
が期待できる。しかし前記引用した方法で製造した製剤
においては、生物学的活性物質を高濃度に含有させた場
合や、水溶性の高い生物学的活性物質を含有させた場合
、種々の要因が重なり生物学的活性物質の第1胃バイパ
ス性がほとんど発現しない。On the other hand, bypass oils have higher melting points and better thermal stability than hydrogenated oils, etc., so preparations in which biologically active substances are coated and protected with bypass oils are expected to have excellent thermal stability. . However, in the preparations manufactured by the method cited above, when a biologically active substance is contained in a high concentration or a highly water-soluble biologically active substance is contained, various factors come together and the biological The active substance exhibits little ruminal bypassing properties.
本発明は、生物学的活性物質の第1胃バイパス性に優れ
た反衝動物用飼料添加剤を提供することを、その目的と
する。An object of the present invention is to provide an anti-impulse feed additive that has excellent ruminal bypass properties for biologically active substances.
本発明者等は、前記目的を達成すべく鋭意研究した結果
、生物学的活性物質と保護物質とを含有する核顆粒を、
さらに脂肪酸の2価金属塩からなる保護皮膜で被覆する
ことにより、第1胃バイパス性が著しく向上することを
見出し、本発明を完成した。As a result of intensive research to achieve the above object, the present inventors have developed nuclear granules containing biologically active substances and protective substances.
Furthermore, it was discovered that the rumen bypass property was significantly improved by coating with a protective film made of a divalent metal salt of a fatty acid, and the present invention was completed based on this finding.
本発明は、生物学的活性物質と保護物質とを含有する核
顆粒を、中性域では不溶性であり酸性域では分解性を示
す脂肪酸塩の保護皮膜で被覆したことを特徴とする反芻
動物用飼料添加剤である。The present invention provides a method for use in ruminants, characterized in that core granules containing a biologically active substance and a protective substance are coated with a protective coating of a fatty acid salt that is insoluble in a neutral range and decomposable in an acidic range. It is a feed additive.
本発明において、生物学的活性物質は、動物に供与して
肥育促進、疾病予防、疾病治療等の活性を示す物質であ
り、特に反芻動物に経口投与した場合、第1胃内に存在
する微生物により分解され、そのままでは有効に利用さ
れにくい物質である。In the present invention, biologically active substances are substances that are given to animals and exhibit activities such as promoting fattening, preventing diseases, and treating diseases. In particular, when orally administered to ruminants, microorganisms present in the rumen It is a substance that is difficult to utilize effectively as it is.
たとえばアミノ酸類:メチオニン、リジン、トリプトフ
ァン等、N−アシルアミノ酸類・N−ステアロイルメチ
オニン、N−オレイルメチオニン。For example, amino acids: methionine, lysine, tryptophan, etc., N-acyl amino acids, N-stearoylmethionine, N-oleylmethionine.
N−ヒドロキシメチルメチオニンのカルシウム塩等、ア
ミノ酸の塩類:リジン塩酸塩等、アミノ酸のヒドロキシ
同族化合物類:2−ヒドロキシ−4メチルメルカプト酪
酸およびそのカルシウム塩等、タンパク質類:無粉末、
カゼイン、馬鈴薯蛋白、大豆蛋白等、ビタミン類:ビタ
ミンA、ビタミンA酢酸エステル、ビタミンAパルミチ
ン酸エステル、ビタミンD!+ビタミンE、ニコチン酸
およびニコチン酸アミド、パントテン酸カルシウム。Amino acid salts, such as the calcium salt of N-hydroxymethylmethionine: lysine hydrochloride, etc., hydroxy analogues of amino acids: 2-hydroxy-4-methylmercaptobutyric acid and its calcium salt, etc., Proteins: powder-free,
Casein, potato protein, soybean protein, etc., vitamins: vitamin A, vitamin A acetate, vitamin A palmitate, vitamin D! + Vitamin E, nicotinic acid and nicotinamide, calcium pantothenate.
β−カロチン等、酵素類:酸性プロテアーゼ等、炭水化
物類:ぶどう糖等、獣医薬類:ペニシリン。β-carotene, etc., enzymes: acid protease, etc., carbohydrates: glucose, etc., veterinary drugs: penicillin.
テトラサイクリン等の抗生物質、ネグフォン等の駆虫薬
等が挙げられ、それらの1種または2種以上が使用され
る。Examples include antibiotics such as tetracycline, anthelmintics such as Negfon, and one or more of these may be used.
核顆粒製造時のバインダーとして使用する保護物質は、
pH5〜8の中性域にある反芻動物の第1胃胃液に安定
で、pH3以下の強酸性域の第4胃胃液または第4胃以
降の消化器官の消化液で分解するものであればよい。The protective substance used as a binder during the production of nuclear granules is
Any material that is stable in the rumen juice of ruminants in the neutral pH range of 5 to 8 and decomposed in the abomasal gastric juice in the strongly acidic range of pH 3 or less or the digestive juices of the digestive organs after the abomasum may be used. .
たとえば炭素数8〜22の直鎖または分枝を有する飽和
または不飽和のモノカルボン酸およびその塩、硬化した
動植物油等が挙げられ、それらの1種または2種以上が
使用される。好ましくは炭素数14〜18の直鎖または
分枝を有する飽和または不飽和の脂肪酸の2価金属塩を
、さらに好ましくはそれらのカルシウム塩を使用する。For example, linear or branched saturated or unsaturated monocarboxylic acids having 8 to 22 carbon atoms and their salts, hardened animal and vegetable oils, etc. may be mentioned, and one or more of these may be used. Preferably, divalent metal salts of linear or branched saturated or unsaturated fatty acids having 14 to 18 carbon atoms are used, and more preferably their calcium salts are used.
核顆粒は、前記生物学的活性物質の1種または2種以上
を、保護物質をバインダーとして顆粒化したものであり
、通常、加熱軟化した保護物質に生物学的活性物質粉末
を添加して均一に混合した後、冷却固化して粒状化する
ことにより製造される。Core granules are made by granulating one or more of the biologically active substances mentioned above and using a protective substance as a binder, and are usually made by adding biologically active substance powder to the protective substance that has been softened by heat to make it homogeneous. It is manufactured by mixing the mixture with the following ingredients, cooling it, solidifying it, and granulating it.
粒状化法として、押出造粒法、攪拌造粒法等、−船釣な
造粒法を採用することができる。As the granulation method, a conventional granulation method such as an extrusion granulation method or an agitation granulation method can be employed.
核顆粒は、より球状に近い形状であることが好ましい。It is preferable that the nuclear granules have a shape closer to a spherical shape.
保護皮膜に使用する中性域では不溶性であり、酸性域で
は分解性を示す脂肪酸塩は、前記保護物質と同様に反芻
動物の第1胃胃液に安定で第4胃胃液で分解する脂肪酸
の塩、たとえば前記引用した炭素数14.16および/
または18の脂肪酸のカルシウム塩またはマグネシウム
塩、天然油脂から製造される混合脂肪酸のカルシウム塩
等が使用される。The fatty acid salt used for the protective film is insoluble in a neutral range and degradable in an acidic range, and is a salt of a fatty acid that is stable in the ruminal juice of a ruminant and decomposed in the abomasal juice, similar to the above-mentioned protective substance. , for example, the carbon number 14.16 and /
Alternatively, calcium salts or magnesium salts of 18 fatty acids, calcium salts of mixed fatty acids produced from natural oils and fats, etc. are used.
好ましくは融点が30〜50℃、さらに好ましくは35
〜45℃の混合脂肪酸のカルシウム塩を使用する。Preferably the melting point is 30 to 50°C, more preferably 35°C.
Use calcium salts of mixed fatty acids at ~45°C.
保護皮膜による核顆粒の被覆は、ヘンシェルミキサー等
を用い、核顆粒をその表面が僅かに溶融する程度に加熱
した中に、被覆物質の粉末を添加しながら攪拌する方法
で容易に被覆を形成することができる。The core granules can be easily coated with a protective film by heating the core granules to the extent that their surfaces are slightly melted using a Henschel mixer, etc., and stirring the core granules while adding the powder of the coating substance. be able to.
本発明は、前記したように生物学的活性物質を含有する
核顆粒を、さらに中性域では不溶性であり、酸性域では
分解性を示す脂肪酸塩からなる保護皮膜で被覆したこと
を特徴とする反芻動物用飼料添加剤である。The present invention is characterized in that, as described above, the core granules containing biologically active substances are further coated with a protective film made of a fatty acid salt that is insoluble in a neutral range and degradable in an acidic range. It is a feed additive for ruminants.
本発明において、保護皮膜が中性域で不溶性であること
から、pH5〜8の範囲にある反芻動物の第1胃の胃液
に極めて安定であり、また酸性域で分解性であることか
らpH3以下の反芻動物の第4胃で容易に分解する。そ
の結果、核顆粒中に含まれる生物学的活性物質が反芻動
物の第4胃で溶出し、それ以降の消化器官で効率よく吸
収される。また保護皮膜に用いた脂肪酸塩も第4胃以降
の消化器官で分解、吸収され、反芻動物のエネルギー源
として利用される。In the present invention, since the protective film is insoluble in the neutral range, it is extremely stable in the rumen gastric fluid of ruminants in the pH range of 5 to 8, and is degradable in the acidic range, so it has a pH of 3 or lower. Easily degraded in the abomasum of ruminants. As a result, the biologically active substances contained in the nuclear granules are eluted in the abomasum of the ruminant and are efficiently absorbed in the subsequent digestive organs. Furthermore, the fatty acid salt used in the protective film is also decomposed and absorbed in the digestive organs starting from the abomasum, and is used as an energy source for ruminants.
また核顆粒製造時のバインダーとして、それ自体中性域
で不溶性で酸性域で分解性の保護物質を用いることによ
り、生物学的活性物質の第1胃バイパス性および第4胃
以降の消化器官における放出性が向上する。特に保護皮
膜と同種の脂肪酸カルシウムを採用することにより、核
顆粒と皮膜との結合力が強化され、その結果、反芻によ
る製剤の破壊も減少し生物学的活性物質の第1胃バイパ
ス率がさらに向上する。In addition, by using a protective substance that is insoluble in the neutral range and decomposable in the acidic range as a binder during the production of nuclear granules, it is possible to improve the ruminal bypass properties of biologically active substances and to improve the ability of the biologically active substances to be absorbed in the digestive organs from the abomasum onwards. Improves release properties. In particular, by using the same type of fatty acid calcium as the protective coating, the binding force between the core granules and the coating is strengthened, and as a result, the destruction of the preparation due to rumination is reduced, further increasing the ruminal bypass rate of biologically active substances. improves.
さらに本製剤は、軟化温度が高いため、保存時の熱安定
性に優れるだけでなく、濃厚飼料をペレット化する場合
にその成分として添加し、反衝動物に生物学的活性物質
を投与する製剤としても有効である。In addition, this formulation has a high softening temperature, so it not only has excellent thermal stability during storage, but also can be added as an ingredient when pelletizing concentrate feed to administer biologically active substances to anti-impulse foods. It is also effective as
本発明を、実施例および比較例によりさらに詳細に説明
する。The present invention will be explained in more detail by Examples and Comparative Examples.
ただし、本発明の範囲は、以下の実施例により何等の制
限を受けるものではない。However, the scope of the present invention is not limited in any way by the following examples.
なお、以下の鋼中において、1部」および「%」は、特
に断りのない限り重量基準である。In addition, in the following steel, "1 part" and "%" are based on weight unless otherwise specified.
(1)核顆粒の調製
融点43°Cの牛脂脂肪酸のカルシウム塩とメチオニン
粉末またはりシン塩酸塩粉末とを混合し、押出機を用い
て紐状に押し出し、ホットカットして粒径0.5〜3
m mの核顆粒: A−1〜A−6を調製した。(1) Preparation of core granules A calcium salt of beef tallow fatty acid with a melting point of 43°C and methionine powder or risin hydrochloride powder are mixed, extruded into a string using an extruder, and hot cut to have a particle size of 0.5. ~3
Nuclear granules of mm: A-1 to A-6 were prepared.
得られた核顆粒の組成および粒径を第1表中に示す。The composition and particle size of the obtained core granules are shown in Table 1.
(2)反芻動物用飼料添加剤の調製
前記第(1)項で使用した脂肪酸カルシウムの100μ
m以下の粉末および前記第(1)項で調製した核顆粒:
A−1−A−6を攪拌装置に仕込み、加熱下に攪拌し、
核顆粒の表面を脂肪酸カルシウムの保護皮膜で被覆した
反芻動物用飼料添加剤を調製した。(2) Preparation of feed additive for ruminants 100μ of fatty acid calcium used in the above item (1)
m or less powder and core granules prepared in the above item (1):
A-1-A-6 was charged into a stirring device, stirred while heating,
A feed additive for ruminants was prepared in which the surface of nuclear granules was coated with a protective film of fatty acid calcium.
得られた反芻動物用飼料添加剤の被覆量および生物学的
活性物質の含有量を第1表中に示す。The coating amount and biologically active substance content of the obtained feed additive for ruminants are shown in Table 1.
(3)生物学的活性物質の溶出試験
前記第(2)項で調製した反芻動物用飼料添加剤および
比較のための前記第(1)項で調製した核顆粒のそれぞ
れの各2gを、牛の第1胃胃液に対応するTris緩衝
液200ccに浸漬し、37℃の温度下に24時間振盪
保持した後、Tris緩衝液から取り出し牛の第4胃胃
液に対応する0、 05 MC=mo Il ・dm−
3)塩酸200ccに浸漬し、37℃の温度下にさらに
4時間振盪した。ついで0、05 M塩酸から取り出し
た製剤を、牛の小腸対応液200ccに浸漬し、37℃
の温度下にさらに4時間振盪した。(3) Dissolution test of biologically active substances 2 g of each of the ruminant feed additive prepared in the above item (2) and the nuclear granules prepared in the above item (1) for comparison were administered to cattle. It was immersed in 200 cc of Tris buffer corresponding to the ruminal juice of a cow, and kept shaking at a temperature of 37°C for 24 hours, and then taken out from the Tris buffer and 0, 05 MC=mo Il corresponding to the rumen juice of a cow.・dm-
3) It was immersed in 200 cc of hydrochloric acid and further shaken at a temperature of 37° C. for 4 hours. Next, the preparation taken out from the 0.05 M hydrochloric acid was immersed in 200 cc of bovine small intestine solution and heated to 37°C.
The mixture was further shaken for 4 hours at a temperature of .
Tris緩衝液
Tris[)リス(ヒドロキシメチル)アミノメタン〕
6.06 gを、292mlの0.1 M塩酸に溶解し
、水で1000mlに希釈したpH8,0の溶液
ついで、Tris緩衝液、0.05 M塩酸および小腸
対応液に溶出したメチオニンおよびリシンを、ヨード滴
定法またはニンヒドリン発色法により定量した。Tris buffer Tris [) Lis (hydroxymethyl) aminomethane]
6.06 g was dissolved in 292 ml of 0.1 M hydrochloric acid, diluted to 1000 ml with water, pH 8.0, and the methionine and lysine eluted in Tris buffer, 0.05 M hydrochloric acid, and small intestine corresponding solution were added. , determined by iodometry or ninhydrin colorimetry.
試験結果を、第1表中に示す。The test results are shown in Table 1.
第1表に示したように、本発明の脂肪酸カルシウムの保
護皮膜により被覆した反芻動物用飼料添加剤においては
、第1胃対応液に対する生物学的活性物質の溶出率は極
めて低く、かつ第4胃対応液および小腸対応液で残部の
大部分が溶出する。As shown in Table 1, in the feed additive for ruminants coated with the protective film of fatty acid calcium of the present invention, the dissolution rate of biologically active substances in the rumen fluid is extremely low, and the Most of the remainder is eluted in the gastric and small intestine fluids.
これに対し、保護皮膜で被覆されていない製剤(比較例
参照)においては、生物学的活性物質の第1胃対応液に
対する溶出率が大きく、生物学的活性物質の50%程度
しか第1胃をバイパスしない。On the other hand, in preparations that are not coated with a protective film (see Comparative Example), the dissolution rate of biologically active substances in the ruminal fluid is large, and only about 50% of the biologically active substances are dissolved in the ruminal fluid. Do not bypass.
本発明の反芻動物用飼料添加剤は、前記実施例にも示し
たように、反芻動物に経口投与した場合に、それに含ま
れる生物学的活性物質の第1胃バイパス性が極めて優れ
ている。As shown in the examples above, the feed additive for ruminants of the present invention has extremely excellent rumen bypass properties for the biologically active substances contained therein when orally administered to ruminants.
またそのバイパス性を付与するために使用した脂肪酸塩
も、第4胃以降の消化器官で分解、吸収され反芻動物の
エネルギー源として有効に利用される。Furthermore, the fatty acid salt used to impart bypass properties is also decomposed and absorbed in the digestive organs starting from the abomasum, and is effectively used as an energy source for ruminants.
本発明は、経口投与した場合に反芻動物の第1胃で分解
されやすい生物学的活性物質を、第1胃をバイパスさせ
第4胃以降の消化器官で高効率で吸収させるに好適な反
芻動物用飼料添加剤を提供するものであり、その産業上
、特に畜産分野における意義は極めて大きい。The present invention is directed to a ruminant animal suitable for bypassing the rumen and absorbing biologically active substances that are easily degraded in the rumen of the ruminant when administered orally and with high efficiency in the digestive organs from the abomasum onwards. It provides feed additives for livestock, and its significance in industry, especially in the livestock field, is extremely large.
Claims (3)
を、中性域では不溶性であり酸性域では分解性を示す脂
肪酸塩の保護皮膜で被覆したことを特徴とする反芻動物
用飼料添加剤(1) Feed for ruminants, characterized in that core granules containing biologically active substances and protective substances are coated with a protective coating of fatty acid salts that is insoluble in neutral ranges and decomposable in acidic ranges. Additive
メチオニン、リジン塩酸塩、ビタミン類よりなる群から
選ばれた少なくとも1種である反芻動物用飼料添加剤(2) A feed additive for ruminants according to claim (1), wherein the biologically active substance is at least one selected from the group consisting of methionine, lysine hydrochloride, and vitamins.
膜と同種の脂肪酸塩である反芻動物用飼料添加剤(4)
請求項第(1)項において、保護皮膜が融点30〜50
℃の範囲にある混合脂肪酸のカルシウム塩である反芻動
物用飼料添加剤(3) A feed additive for ruminants according to claim (1), wherein the protective substance is a fatty acid salt of the same type as the protective film (4)
In claim (1), the protective film has a melting point of 30 to 50.
Feed additive for ruminants that is a calcium salt of mixed fatty acids in the range of °C
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2080804A JPH03280836A (en) | 1990-03-30 | 1990-03-30 | Feed additive for ruminant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2080804A JPH03280836A (en) | 1990-03-30 | 1990-03-30 | Feed additive for ruminant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH03280836A true JPH03280836A (en) | 1991-12-11 |
Family
ID=13728654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2080804A Pending JPH03280836A (en) | 1990-03-30 | 1990-03-30 | Feed additive for ruminant |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH03280836A (en) |
-
1990
- 1990-03-30 JP JP2080804A patent/JPH03280836A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR870000841B1 (en) | Method for preparing granule containg physiologically-active substance | |
| NO157365B (en) | CONDITION FOR DRUGS. | |
| JPS5910780B2 (en) | Feed additives passing through the rumen of ruminants | |
| KR880002184B1 (en) | Feed additive composition | |
| JPS6137054A (en) | Particle for feed additive | |
| JPS61195653A (en) | Particle for ruminant | |
| WO1991012731A1 (en) | Feed additive for ruminant | |
| JP3266608B2 (en) | Ruminant feed additives | |
| JPH03280841A (en) | Feed additive for ruminant | |
| JPS63294747A (en) | Vitamin-containing feed additive for ruminant | |
| JPH03280836A (en) | Feed additive for ruminant | |
| JPH05192096A (en) | Feed additive composition for ruminant | |
| JP2645497B2 (en) | Ruminant feed additives | |
| JPH03280838A (en) | Feed additive for ruminant | |
| JP2847879B2 (en) | Ruminant feed additives | |
| JPH10215789A (en) | Feed additive for ruminant | |
| JPH03280837A (en) | Feed additive for ruminant | |
| JPH0411848A (en) | Feed additive for ruminant | |
| JPS60168351A (en) | Feed additive composition | |
| JPS6128351A (en) | Preparation of feed additive for ruminant | |
| JP2533352B2 (en) | Feed additives for ruminants | |
| JPH03280839A (en) | Feed additive for ruminant | |
| JPH02163043A (en) | Feed additive for ruminant | |
| JP2847880B2 (en) | Ruminant feed additives | |
| JPS60141243A (en) | Feed additive composition for ruminant |